Congressional Researchers Call Out FDA For Missing Deadline To Publish Cannabinoid List And Define Hemp ‘Containers’
Congressional researchers are noting that the Food and Drug Administration (FDA) has missed a legal deadline to publish a list of known cannabinoids as federal hemp laws are set to change later this year in a way that stakeholders argue will upend the existing market. As part of appropriations legislation that President Donald Trump signed […]
Connecticut Governor Signs Bill To Expand Psychedelics Pilot Program In Preparation For Federal FDA Approval
Connecticut’s governor has signed a bill to expand a pilot program that’s meant to explore the therapeutic potential of psychedelics such as psilocybin and MDMA. The legislation sponsored by the Joint Committee on Public Health cleared the House of Representatives in 122-27 vote last month after passing the Senate by a unanimous 35-0 vote in […]
Bipartisan Lawmakers Push FDA To Speed Up Approval Of Psychedelic Therapies
A bipartisan coalition of 32 members of Congress is urging federal health officials to expedite ongoing reviews of psychedelic therapies. “For many individuals, current treatment options remain insufficient, deepening an already urgent public health crisis,” the lawmakers, led by Reps. Jack Bergman (R-MI) and Lou Correa (D-CA), co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, […]